Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.26434/chemrxiv-2024-d62kp
Publication URI: http://dx.doi.org/10.26434/chemrxiv-2024-d62kp
Type: Preprint